{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Feasibility and tolerability will be evaluated based on participants completing second transplant with tolerable adverse events","groups":[{"description":"Participants underwent a second treatment with high dose chemotherapy and stem cell transplant","id":"OG000","title":"Second Transplant"}],"populationDescription":"No data were collected or analyzed due to study termination","reportingStatus":"POSTED","timeFrame":"3 months after treatment and annually","title":"Feasibility and Tolerability","type":"PRIMARY"}